In September 2025, the Department of Justice (“DOJ”) announced a $4.2 million settlement with the former CEO of True Health Diagnostics, LLC (“True Health”), Christopher Grottenthaler, as well as a $1.8 million settlement with various marketing professionals and physicians to resolve allegations under the Anti-Kickback Statute and False Claims Act. Grottenhaler was accused of working with various marketers to make payments to physicians through management service organizations purportedly providing True…
Abstract In December 2025, CERATIZIT USA LLC agreed to pay $54.4 million to resolve False Claims Act (“FCA”) allegations that it improperly avoided U.S. customs duties on tungsten carbide products imported from China. According to the Department of Justice (“DOJ”), the company misclassified the country of origin for these goods to avoid antidumping, countervailing duties, and Section 301 duties. This case illustrates how customs fraud can give rise to significant liability under the False Claims Act, and how whistleblowers remain key to uncovering corporate…
There are serious legal consequences to violating the False Claims Act (“FCA”), particularly in cases involving illegal kickbacks in the healthcare industry, as demonstrated by the $17 million Bard fraud settlement. This settlement resolved allegations that C.R. Bard, Inc. and its affiliates provided unlawful incentives to urology practice groups to influence medical device prescriptions. The lawsuit alleged that Bard and its subsidiaries improperly offered discounts, free samples, and cost-saving benefits…
On July 30, 2024, Chief U.S. District Judge Mitchell S. Goldberg of the Eastern District of Pennsylvania denied a request to appeal his interpretation of the Centers for Medicare and Medicaid Services' regulations from CVS Caremark Corp. ("Defendant" or "Caremark" or the "Company") in a qui tam lawsuit against the Company for falsely reporting prescription drug prices to the government in violation of the False Claims Act ("FCA"), 31 U.S.C.…
The False Claims Act (FCA) is a legal measure designed to protect the integrity of government expenditures. Enacted during the American Civil War in 1863, its primary purpose was to curb defense contractor fraud, an objective that has since broadened to encompass a range of fraudulent activities against the federal government. At Miller Shah LLP, we continue that commitment to justice by supporting whistleblowers who bring fraudulent activities to light…
On July 21, 2023, the Department of Justice (“DOJ”) announced that Booz Allen Hamilton Holding Corporation (“Booz Allen” or the “Company”), a Virginia-based provider of data analytics, digital solutions, and consulting services, has agreed to pay $377.45 million to resolve alleged violations of the False Claims Act, 31 U.S.C. §§ 3729–3733 (“FCA”). The settlement, one of the biggest procurement fraud settlements in DOJ history, specifically resolves allegations that Booz Allen…
On September 13, 2022, the Department of Justice (“DOJ”) announced its first settlement with a Paycheck Protection Program (“PPP”) lender pursuant to the False Claims Act (“FCA”). The agreement resolves allegations that Prosperity Bank (“Prosperity” or the “Bank”), a regional bank throughout Texas and Oklahoma, improperly processed a PPP loan and secured a processing fee to which it was not entitled. Prosperity agreed to settle the claims for $18,000, and…
On August 18, 2022, a District Judge in the United States District Court for the Southern District of California granted in part and denied in part the motion to dismiss the False Claims Act lawsuit against Abbott Laboratories, Inc. a/k/a Abbott Laboratories, Abbott Cardiovascular Systems Inc., and Abbott Vascular Inc., (collectively, “Abbott” or the “Company”), sustaining the federal claims but dismissing the state claims in the action. The False Claims Act,…
On August 29, 2022, Nathan C. Zipperian of Miller Shah LLP (www.millershah.com), counsel for Plaintiff-Relator, Gregory Kuzma (“Relator”) announced Northern Arizona Healthcare (“NAHC”), Flagstaff Medical Center (“FMC”), and Health First Foundation - Northern Arizona (formerly Northern Arizona Healthcare Foundation) (“NAHF”) (collectively, “Defendants”) agreed to pay a total of $4.5 million to settle a lawsuit alleging that a 2017 Medicaid Disproportionate Share Hospital (“DSH”) payment of approximately $4.775 million to FMC…
On July 20, 2022, Biogen, Inc. (“Biogen” or the “Company”), formerly known as Biogen Idec, Inc., agreed to pay $900 million to resolve allegations that the Company violated the federal Anti-Kickback Statute (“AKS”) and False Claims Act (“FCA”) by paying physicians to prescribe its Multiple Sclerosis (“MS”) drugs. After a decade of litigation, the parties agreed to settle just one week before trial was set to begin. The FCA allows…
PA Philadelphia | 866-540-5505
NY New York City | 866-540-5505
NY New York City | 866-540-5505
NY New York City | 866-540-5505
NY New York City | 866-540-5505
CT Chester | 866-540-5505
PA Philadelphia | 866-540-5505
NY New York City | 866-540-5505
PA Philadelphia | 866-540-5505
CA San Francisco | 866-540-5505
FL Fort Lauderdale | 866-540-5505
NY New York City | 866-540-5505
PA Philadelphia | 866-540-5505
CT Chester | 866-540-5505
NY New York City | 866-540-5505
PA Philadelphia | 866-540-5505
CA Los Angeles | 866-540-5505
CA Los Angeles | 866-540-5505
CT Chester | 866-540-5505
CT Chester | 866-540-5505
FL Fort Lauderdale | 866-540-5505
CT Chester | 866-540-5505
NY New York City | 866-540-5505
PA Philadelphia | 866-540-5505
NY New York City | 866-540-5505
PA Philadelphia | 866-540-5505
CA San Diego | 866-540-5505
PA Philadelphia | 866-540-5505
CT Chester | 866-540-5505
NY New York City | 866-540-5505
NY New York City | 866-540-5505
NY New York City | 866-540-5505
PA Philadelphia | 866-540-5505
PA Philadelphia | 866-540-5505
FL Fort Lauderdale | 866-540-5505
NJ Hoboken | 866-540-5505
NY New York City | 866-540-5505
PA Philadelphia | 866-540-5505
PA Philadelphia | 866-540-5505
PA Philadelphia | 866-540-5505
CA San Francisco | 866-540-5505
CT Chester | 866-540-5505
NY New York City | 866-540-5505
CT Chester | 866-540-5505
PA Philadelphia | 866-540-5505
CA San Diego | 866-540-5505
PA Philadelphia | 866-540-5505
PA Philadelphia | 866-540-5505
PA Philadelphia | 866-540-5505
CA Los Angeles | 310-203-0600